Chitosan coated PLA nanoparticles for ophthalmic delivery: Characterization, in-vitro and in-vivo study in rabbit eye

Journal of Biomedical Nanotechnology

Volumn 6, Issue 6, 2010, Pages 648-657

  Nagarwal, Ramesh C ^a   Singh, P N ^a   Kant, S ^b   Maiti, P ^a   Pandit, J K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

5 fluorouracil; Aqueous humor; Chitosan; Cornea; Nanoparticles; Ophthalmic delivery; Poloxomer; Poly (D, L lactic acid); Polyvinyl alcohol

Indexed keywords

5-FLUOROURACIL; AQUEOUS HUMOR; CORNEA; OPHTHALMIC DELIVERY; POLOXOMER; POLY (D, L-LACTIC ACID);

ATOMIC FORCE MICROSCOPY; BODY FLUIDS; CHITIN; CHITOSAN; DYNAMIC LIGHT SCATTERING; EXPERIMENTS; LACTIC ACID; ORGANIC POLYMERS; SCANNING ELECTRON MICROSCOPY;

NANOPARTICLES;

CHITOSAN; FLUOROURACIL; MUCIN; NANOPARTICLE; POLYLACTIC ACID; ANTIMETABOLITE; POLYLYSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORNEA; DRUG INSTILLATION; DRUG PENETRATION; DRUG STABILITY; ENCAPSULATION; FEMALE; GOAT; MALE; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; RABBIT; VISCOSITY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTIMETABOLITES; CHITOSAN; CORNEA; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FLUOROURACIL; GOATS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; POLYLYSINE; RABBITS;

EID: 79953016653     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2010.1168     Document Type: Article

References (25)

1. A. Al-Barrag, M. Al-shaer, N. Al-Matary, and M. Al-Hamdani, 5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea. Clin. Ophthalmol. 4, 801 (2010).
2. E. Midena, C. D. Angeli, M. Valenti, V. De Belvis, and P. Boccato, Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br. J. Ophthalmol. 84, 268 (2000).
3. R. C. Nagarwa, S. Kant, P. N. Singh, P. Maiti, and J. K. Pandit, Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J. Controlled Release 136, 2 (2009).
4. P. Wu, X. He, K. Wang, W. Tan, C. He, and M. Zheng, A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J. Biomed. Nanotechnol. 5, 557 (2009)
5. N. Csaba, M. Köping-Höggård, E. Fernandez-Megia, R. Novoa-Carballal, R. Riguera, and M. J. Alonso, Ionically crosslinked chitosan nanoparticles as gene delivery systems: Effect of PEGylation degree on in vitro and in vivo gene transfer. J. Biomed. Nanotechnol. 5, 162 (2009)
6. W. Yang, T. Wang, J. Fu, and N. He, Chitosan/sodium tripolyphosphate nanoparticles: Preparation, characterization and application as drug carrier. J. Biomed. Nanotechnol. 5, 591 (2009).
7. O. Felt, P. Furrer, J. M. Mayer, B. Plazonnet, P. Buri, and R. Gurny, Topical use of chitosan in ophthalmology: Tolerance assessment and evaluation of pre-corneal retention. Int. J. Pharm. 53, 41 (1999).
8. A. M. De Campos, A. Sanchez, and M. J. Alonso, Chitosan nanoparticles: A new vehicle for the improvement of the delivery of the drugs to the ocular surface, application to cyclosporine A. Int. J. Pharm. 224, 159 (2001).
9. A. Muvaffak, I. Gurhan, U. Gunduz, and N. Hasirci, Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: Microsphere-antibody conjugate. J. Drug. Target 13, 151 (2005).
10. K. Santhi, S. A. Dhanaraj, J. Vinod, S. Ponnusankar, and B. Suresh, A study on the preparation and anti-tumor efficacy of bovine serum albumin nanospheres containing 5-fluorouracil. Drug. Dev. Ind. Pharm. 28, 1171 (2002).
11. E. Fournier, C. Passirani, N. Colin, P. Breton, S. Sagodira, and J. P. Benoit, Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers. Eur. J. Pharm. Biopharm. 57, 189 (2004).
12. P. Menei, E. Jadaud, N. Faisant, M. Boisdron-Celle, S. Michalak, D. Fournier, M. Delhaye, and J. P. Benoit, Stereotaxic implantation of 5-fluorouracil releasing microspheres in malignant glioma: A phase I study. Cancer 100, 405 (2004).
13. R. L. Sastre, R. Olmo, C. Teijon, E. Muniz, J. M. Teijon, and M. D. Blanco, 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug - loaded microspheres prepared by-drying poly (D, L-lactide) and poly (D, L-lactide-co-glycolide) polymers. Int. J. Pharm. 338, 180 (2007).
14. Y. Zambito, A. Baggiani, V. Carelli, M. F. Seraf'm, and G. Di Colo, Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon. J. Controlled Release 102, 669 (2005).
15. M. Simeonova, R. Velichkova, G. Ivanova, V. Enchev, and I. Abrahams, Poly (butycyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil. Int. J. Pharm. 263, 133 (2003).
16. C. Giannavola, C. Bueolo, A. Maltese, M. A.Vandelli, G. Puglisi, V. H. L. Lee, and M. Fresta, Influence of preparation conditions on acyclovir-loaded poly-D,L-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm. Res. 20, 584 (2003).
17. I. Massai, D. Lamalle, S. Munier, B. Verrier, Y. Ataman-Onal, and T. Delair, Poly (D, L-lactide acid) and chitosan complexe: Interaction with plasmid DNA. Colloids Surf. A: Physiochem. Eng. Aspects 255, 65 (2005).
18. P. Calvo, J. L. Vila-Jato, and M. J. Alonso, Evaluation of cationic polymer-coated nanocapsules as ocular carriers. Int. J. Pharm. 53, 41 (1997).
19. P. K. Pawar and D. K. Majumdar, Effect of formulation factors on in-vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep and buffalo corneas. AAPS PharmSciTech. 7, E1 (2006).
20. O. McDonald and J. S. Shedduck, Eye irritation, Advance in Modern Toxicology, edited by F. M. Marzulli and H. I. Maibach, Jone Wiley & Sons, New York (1977), Vol. 4.
21. P. Costa and J. M. S. Lobo, Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13, 123 (2001).
22. S. Munier, I. Messai, T. Delair, B. Verrier, and Y. A. Önal, Cationic PLA nanoparticles for DNA delivery: Comparision of three surface polycations for DNA binding, protection and transfection properties. Colloids Surf. B. 43, 163 (2005).
23. X. B. Yuan, Y. B. Yuan, W. Jiang, J. Liu, E. J. Tian, H. M. Shun, D. H. Huang, X. Y. Yuan, H. Li, and J. Sheng, Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation. Int. J. Pharm. 349, 241 (2008).
24. J. K. Greaves and C. G. Wilson, Treatment of disease of the eye with mucoadhesive delivery systems. Adv. Drug Del. Rev. 11, 349 (1996).
25. X. M. Li, Y. L. Xu, G. G. Chen, P. Wei, and Q. Ping, PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization- emulsification as the preparation method and in vitrolin vivo studies. Drug. Dev. Ind. Pharm. 34, 107 (2008).